One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Identifying Patients With Low-Risk Locoregionally Advanced Nasopharyngeal Carcinoma by Plasma Epstein-Barr Virus DNA for Chemotherapy Deintensification: Quo Vadis?.
Ng, Wai-Tong MD 1,2; Chua, Melvin L.K. PhD 3,4,5,; Lee, Anne W.M. MD 1,2,
doi : 10.1200/JCO.22.00099
Volume 40(11) pgs. 1135-1265 April 10, 2022
Naive T-Cell Depletion to Prevent GVHD: Searching for a Better Mousetrap.
Soiffer, Robert J. MD 1,,
doi : 10.1200/JCO.22.00105
Improving Outcomes for High-Risk Hormone Receptor-Positive Breast Cancer With CDK Inhibition.
Hicks, David MD 1,; O'Regan, Ruth M. MD 2,3,,
doi : 10.1200/JCO.21.02850
Disease Modification in Myelofibrosis: An Elusive Goal?.
Vachhani, Pankit MD 1,; Verstovsek, Srdan MD, PhD 2,; Bose, Prithviraj MD 2,,
doi : 10.1200/JCO.21.02246
FDA Approval Summary: Abemaciclib With Endocrine Therapy for High-Risk Early Breast Cancer.
Royce, Melanie MD, PhD 1,; Osgood, Christy MD 1; Mulkey, Flora MS 1,; Bloomquist, Erik PhD 1; Pierce, William F. PharmD, MPH 1; Roy, Arpita PhD 2; Kalavar, Shyam MPH 2; Ghosh, Soma PhD 2; Philip, Reena PhD 2; Rizvi, Fatima PharmD 3; Mixter, Bronwyn D. BA 1,3; Tang, Shenghui PhD 1; Pazdur, Richard MD 3; Beaver, Julia A. MD 1,3; Amiri-Kordestani, Laleh MD 1
doi : 10.1200/JCO.21.02742
Deintensified Chemoradiotherapy for Pretreatment Epstein-Barr Virus DNA-Selected Low-Risk Locoregionally Advanced Nasopharyngeal Carcinoma: A Phase II Randomized Noninferiority Trial.
Li, Xiao-Yun MD 1; Luo, Dong-Hua MD, PhD 1; Guo, Ling MD, PhD 1; Mo, Hao-Yuan MD, PhD 1; Sun, Rui MD, PhD 1; Guo, Shan-Shan MD, PhD 1; Liu, Li-Ting MD, PhD 1; Yang, Zhen-Chong MD 1; Yang, Jin-Hao MD 1; Qiu, Fang MD 1; Sun, Xue-Song MD, PhD 1; Wang, Pan MD 1; Liu, Qing PhD 2; Li, Ji-Bin PhD 2; Tang, Qing-Nan MD, PhD 1; Lin, Chao MD 1; Yang, Qi MD, PhD 1; Liu, Sai-Lan MD, PhD 1; Liang, Yu-Jing MD 1; Jia, Guo-Dong MD 1; Wen, Dong-Xiang MD 1; Guo, Chun-Yan MD 1; Yan, Jin-Jie MD 1; Zhao, Chong MD, PhD 1; Chen, Qiu-Yan MD, PhD 1; Tang, Lin-Quan MD, PhD 1; Mai, Hai-Qiang MD, PhD 1,
doi : 10.1200/JCO.21.01467
Naive T-Cell Depletion to Prevent Chronic Graft-Versus-Host Disease.
Bleakley, Marie BMBS, PhD, MMSc 1,2,,; Sehgal, Alison MD 3,4,; Seropian, Stuart MD 5; Biernacki, Melinda A. MD 1,6,; Krakow, Elizabeth F. MD, MSc 1,6,; Dahlberg, Ann MD 1,2,; Persinger, Heather MA 1; Hilzinger, Barbara BSc 1; Martin, Paul J. MD 1,6,; Carpenter, Paul A. MBBS 1,2,; Flowers, Mary E. MD 1,6,; Voutsinas, Jenna MPH 1; Gooley, Theodore A. PhD 1,7,; Loeb, Keith MD, PhD 1,8; Wood, Brent L. MD, PhD 1,9,; Heimfeld, Shelly PhD 1; Riddell, Stanley R. MD 1,6,; Shlomchik, Warren D. MD 3,4,10,11,
doi : 10.1200/JCO.21.01755
Incidence, Nature, and Consequences of Oncologists' Experiences With Sexual Harassment.
Subbiah, Ishwaria M. MD, MS 1,; Markham, Merry Jennifer MD 2,; Graff, Stephanie L. MD 3,; Matt-Amaral, Laurie B. MD, MPH 4,; Close, Julia L. MD 2; Griffith, Kent A. MS, MPH 5; Jagsi, Reshma MD, DPhil 6,,
doi : 10.1200/JCO.21.02574
Ibrutinib in Combination With Rituximab for Indolent Clinical Forms of Mantle Cell Lymphoma (IMCL-2015): A Multicenter, Open-Label, Single-Arm, Phase II Trial.
Gine, Eva MD 1,2,3,,; de la Cruz, Fatima MD 4,; Jimenez Ubieto, Ana PhD 5; Lopez Jimenez, Javier PhD 6,; Martin Garcia-Sancho, Alejandro MD 3,7,8,; Terol, M. Jose MD 9,10,; Gonzalez Barca, Eva MD 11,; Casanova, Maria MD 12; de la Fuente, Adolfo MD 13,; Marin-Niebla, Ana PhD 14; Muntanola, Ana MD 15; Gonzalez-Lopez, Tomas Jose PhD 16; Aymerich, Marta PhD 2,3,17,18; Setoain, Xavier MD 2,18,19,20,; Cortes-Romera, Montserrat MD 21; Rotger, Amanda MD 22,; Rodriguez, Sonia MD 18,23; Medina Herrera, Alejandro PhD 3,7,24,25,; Garcia Sanz, Ramon PhD 3,7,24,25,; Nadeu, Ferran PhD 2,3,17,18,; Bea, Silvia PhD 2,3,17,18; Campo, Elias PhD 2,3,17,18,; Lopez-Guillermo, Armando MD 1,2,3,18,
doi : 10.1200/JCO.21.02321
H1-Antihistamines Reduce the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus, Hepatitis C Virus, or Dual Hepatitis B Virus-Hepatitis C Virus Infection.
Shen, Yu-Chuan MD 1; Hsu, Hui-Ching MD 1,2; Lin, Tzu-Min MD 2,3; Chang, Yu-Sheng MD 2,4; Hu, Li-Fang MD 3; Chen, Lung-Fang MD 1,2; Lin, Sheng-Hong MD 2,4; Kuo, Pei-I. MD 5; Chen, Wei-Sheng MD 6; Lin, Yi-Chun MS 7; Chen, Jin-Hua PhD 7,8; Liang, Yu-Chih PhD 9,10,11; Chang, Chi-Ching PhD 2,3,
doi : 10.1200/JCO.21.01802
Neoadjuvant Chemoradiotherapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Long-Term Results of the Dutch Randomized PREOPANC Trial.
Versteijne, Eva MD, PhD 1,; van Dam, Jacob L. MD 2; Suker, Mustafa MD, PhD 2; Janssen, Quisette P. MD 2; Groothuis, Karin MSc 3; Akkermans-Vogelaar, Janine M. BSc 3; Besselink, Marc G. MD, PhD 4,; Bonsing, Bert A. MD, PhD 5; Buijsen, Jeroen MD, PhD 6; Busch, Olivier R. MD, PhD 4; Creemers, Geert-Jan M. MD, PhD 7; van Dam, Ronald M. MD, PhD 8,9,10,; Eskens, Ferry A. L. M. MD, PhD 11,; Festen, Sebastiaan MD, PhD 12; de Groot, Jan Willem B. MD, PhD 13,; Groot Koerkamp, Bas MD, PhD 2,; de Hingh, Ignace H. MD, PhD 14,; Homs, Marjolein Y. V. MD, PhD 11,; van Hooft, Jeanin E. MD, PhD 15,16,; Kerver, Emile D. MD 17; Luelmo, Saskia A. C. MD 18; Neelis, Karen J. MD, PhD 19; Nuyttens, Joost MD, PhD 20; Paardekooper, Gabriel M. R. M. MD 21; Patijn, Gijs A. MD, PhD 22; van der Sangen, Maurice J. C. MD, PhD 23; de Vos-Geelen, Judith MD, PhD 24,; Wilmink, Johanna W. MD, PhD 25,; Zwinderman, Aeilko H. PhD 26,; Punt, Cornelis J. MD, PhD 27,; van Tienhoven, Geertjan MD, PhD 1; van Eijck, Casper H. J. MD, PhD 2; for the Dutch Pancreatic Cancer Group
doi : 10.1200/JCO.21.02233
Somatic Genomic Testing in Patients With Metastatic or Advanced Cancer: ASCO Provisional Clinical Opinion.
Chakravarty, Debyani PhD 1,; Johnson, Amber PhD 2; Sklar, Jeffrey MD, PhD 3,; Lindeman, Neal I. MD 4; Moore, Kathleen MD 5,; Ganesan, Shridar MD, PhD 6,; Lovly, Christine M. MD, PhD 7,; Perlmutter, Jane PhD 8; Gray, Stacy W. MA, MD 9,; Hwang, Jimmy MD 10,; Lieu, Christopher MD 11,; Andre, Fabrice MD, PhD 12,; Azad, Nilofer MD 13,; Borad, Mitesh MD 14,; Tafe, Laura MD 15,; Messersmith, Hans MPH 16; Robson, Mark MD 1,; Meric-Bernstam, Funda MD 2,
doi : 10.1200/JCO.21.02767
Propensity Score Matching for Bias Reduction in Genomic Profiling.
Bi, Guoshu PhD; Liang, Jiaqi PhD; Shan, Guangyao PhD; Zhan, Cheng PhD
doi : 10.1200/JCO.21.02449
Reply to G. Bi et al.
Devarakonda, Siddhartha MD; Wu, Ningying MD, PhD; Sankararaman, Sumithra PhD; Govindan, Ramaswamy MD
doi : 10.1200/JCO.21.02945
Efficacy, Molecular Biology, Quality of Life, or Economic Aspects: What Do We Really FOCUS oN?.
Kurreck, Annika MD; Stintzing, Sebastian MD; Modest, Dominik P. MD
doi : 10.1200/JCO.21.02310
Treatment Break Versus Maintenance in Metastatic Colorectal Cancer.
Copur, Mehmet Sitki MD; Kelly, Jacqueline MD, MSc; Tun, Soe Min MD, MSc MBA
doi : 10.1200/JCO.21.02420
Reply to A. Kurreck et al and M.S. Copur et al.
Adams, Richard MD; Wilson, Richard PhD; Brown, Louise PhD; Maughan, Timothy MD
doi : 10.1200/JCO.21.02806
